Comparative proteomic profiling of the serum differentiates pancreatic cancer from chronic pancreatitis.
about
Identification of MST1 as a potential early detection biomarker for colorectal cancer through a proteomic approach.Colorectal cancer patients with different C-reactive protein levels and 5-year survival times can be differentiated with quantitative serum proteomics.Signal-Targeted Therapies and Resistance Mechanisms in Pancreatic Cancer: Future Developments Reside in Proteomics.Plasma Gelsolin: Indicator of Inflammation and Its Potential as a Diagnostic Tool and Therapeutic Target
P2860
Comparative proteomic profiling of the serum differentiates pancreatic cancer from chronic pancreatitis.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Comparative proteomic profilin ...... cer from chronic pancreatitis.
@en
type
label
Comparative proteomic profilin ...... cer from chronic pancreatitis.
@en
prefLabel
Comparative proteomic profilin ...... cer from chronic pancreatitis.
@en
P2093
P2860
P356
P1433
P1476
Comparative proteomic profilin ...... ncer from chronic pancreatitis
@en
P2093
Caj Haglund
Hanna Seppänen
Risto Renkonen
Sakari Joenväärä
P2860
P304
P356
10.1002/CAM4.1107
P407
P577
2017-06-01T00:00:00Z